SNY

Sanofi ADR

Jan 30 • 04:00PM ET

47.04

+0.84 1.82 %

Healthcare • Drug Manufacturers - General • France • NASD

Peers: NVS PFE MRK GSK BMY LLY AZN JNJ ABBV AMGN

| Held by: PVAL PPH FVD AVDE PID FENI BASV BDYN GMOI BUSA

Index	-	P/E	11.74	EPS (ttm)	4.01	Insider Own	0.00%	Shs Outstand	2.42B	Perf Week	-0.34%
Market Cap	113.73B	Forward P/E	8.90	EPS next Y	5.28	Insider Trans	-	Shs Float	2.42B	Perf Month	-3.49%
Enterprise Value	129.00B	PEG	1.19	EPS next Q	1.06	Inst Own	9.87%	Short Float	0.35%	Perf Quarter	-7.18%
Income	8.68B	P/S	2.30	EPS this Y	6.34%	Inst Trans	1.60%	Short Ratio	3.15	Perf Half Y	3.07%
Sales	49.41B	P/B	1.39	EPS next Y	6.40%	ROA	3.87%	Short Interest	8.50M	Perf YTD	-2.93%
Book/sh	33.76	P/C	12.65	EPS next 5Y	7.49%	ROE	6.76%	52W High	60.12 -21.75%	Perf Year	-9.80%
Cash/sh	3.72	P/FCF	10.54	EPS past 3/5Y	0.93% -8.36%	ROIC	8.49%	52W Low	44.62 5.43%	Perf 3Y	-3.78%
Dividend Est.	2.54 (5.40%)	EV/EBITDA	8.56	Sales past 3/5Y	2.90% 3.69%	Gross Margin	72.29%	Volatility	1.50% 1.54%	Perf 5Y	-4.71%
Dividend TTM	2.21 (4.70%)	EV/Sales	2.61	EPS Y/Y TTM	48.03%	Oper. Margin	28.51%	ATR (14)	0.91	Perf 10Y	14.12%
Dividend Ex-Date	May 09, 2025	Quick Ratio	0.94	Sales Y/Y TTM	11.19%	Profit Margin	17.57%	RSI (14)	47.38	Recom	1.83
Dividend Gr. 3/5Y	- -	Current Ratio	1.09	EPS Q/Q	-32.15%	SMA20	-0.51%	Beta	0.43	Target Price	56.90
Payout	66.53%	Debt/Eq	0.28	Sales Q/Q	28.69%	SMA50	-2.49%	Rel Volume	2.23	Prev Close	46.20
Employees	84587	LT Debt/Eq	0.22	Earnings	Jan 29 BMO	SMA200	-4.54%	Avg Volume	2.70M	Price	47.04
IPO	Jul 01, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.11% 3.35%	Trades		Volume	6,022,602	Change	1.82%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Initiated	Citigroup	Neutral
Jan-16-26	Downgrade	UBS	Buy → Neutral
Jan-06-26	Downgrade	Barclays	Overweight → Equal Weight
Dec-09-25	Downgrade	Guggenheim	Buy → Neutral
Dec-08-25	Downgrade	JP Morgan	Overweight → Neutral
Sep-08-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$58
Sep-02-25	Upgrade	Deutsche Bank	Hold → Buy
Aug-08-25	Upgrade	JP Morgan	Neutral → Overweight
Apr-15-25	Initiated	Exane BNP Paribas	Outperform	$65
Mar-21-25	Initiated	Goldman	Neutral	$65
Jan-30-25	Upgrade	Deutsche Bank	Sell → Hold
Jul-26-24	Reiterated	Argus	Buy	$55 → $60
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$55
Jan-16-24	Resumed	UBS	Buy
Dec-05-23	Downgrade	JP Morgan	Overweight → Neutral
Oct-30-23	Downgrade	Stifel	Buy → Hold
Sep-06-23	Upgrade	Berenberg	Hold → Buy
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-28-23	Downgrade	Deutsche Bank	Hold → Sell
Mar-27-23	Upgrade	Barclays	Equal Weight → Overweight

Show Previous Ratings

Jan-30-26 04:02PM	Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
10:56AM	Regeneron Posts Lower Eylea Sales Amid Rising Competition, Plans $2 Billion New Factory (Benzinga)
10:25AM	REGN Q4 Earnings Beat Estimates, Sales Rise on Eylea HD Growth (Zacks)
07:56AM	Sanofi touts strong new launch sales amid looming Dupixent patent expiry (Pharmaceutical Technology)
06:57AM	Amgen gives up on its once-prized eczema drug (BioPharma Dive)
05:22PM	Loading…
Jan-29-26 05:22PM	Analyst Report: Sanofi (Morningstar Research)
05:09PM	Sanofi Q4 Earnings Call Highlights (MarketBeat)
04:57PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:21PM	Sanofi Edges Higher As Immunology Powerhouse, Dupixent, Wallops Forecasts (Investor's Business Daily)
04:03PM	Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com)
11:23AM	TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth (Zacks)
11:21AM	Sanofi Beats on Q4 Earnings, Expects Profitable Growth in 2026 (Zacks)
09:28AM	Sanofi Creeps Higher On 'Essentially In Line' Guidance For 2026 (Investor's Business Daily)
07:08AM	Sanofi Warns Dupixent Is Too Big To Replace As Patent Clock Ticks (Benzinga)
06:56AM	Sanofi expects vaccine sales growth to dip amid challenging environment (BioPharma Dive)
06:06AM	Loading…
06:06AM	Sensorion announces $71.9m reserved offering to expand gene therapy pipeline (Pharmaceutical Business Review)
01:58AM	Sanofi to Launch $1.20 Billion Share Buyback (The Wall Street Journal)
12:06AM	Teva Pharmaceutical Industries Q4 Earnings Call Highlights (MarketBeat)
Jan-28-26 05:42AM	Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies (Pharmaceutical Technology)
03:00AM	Has Novavax cracked the code for survival in the vaccine arena? (Pharma Voice)
Jan-27-26 11:16AM	Citi initiates coverage of European pharma stocks; AstraZeneca best in class (Investing.com)
Jan-26-26 10:06AM	Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag (Benzinga)
06:09AM	Berenberg Bank Remains a Buy on Sanofi (SNY) (Insider Monkey)
Jan-25-26 07:52AM	Big Tech earnings, Fed meeting feature as markets end January with busiest week of Q1: What to watch (Yahoo Finance)
Jan-23-26 08:06AM	Sanofis Dupixent successor heads to regulators after Phase III success (Clinical Trials Arena)
07:02AM	Sanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies (Benzinga)
06:57AM	Sanofi to seek approval of touted eczema drug despite mixed results (BioPharma Dive)
01:29AM	Sanofi Says Its Amlitelimab Drug Showed Promising Results in Treating Eczema (The Wall Street Journal)
Jan-22-26 02:53PM	Sanofi CEO Paul Hudson: AI will change the cost and speed of drug development (CNBC TV)
09:52AM	Sanofi CEO Paul Hudson: AI will improve efficiency and change the cost and speed of drug development (CNBC TV)
01:03AM	Loading…
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-21-26 10:06AM	Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer (Zacks)
06:39AM	Corvus shares nearly triple on positive data for eczema pill (BioPharma Dive)
Jan-20-26 08:50AM	Will Weak Gardasil Sales Continue to Ail MRK Revenues in Q4 Earnings? (Zacks)
Jan-16-26 05:07PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:12PM	Sanofi (SNY) Secures Approval for Cablivi in the US and Plozasiran in China (Insider Monkey)
11:01AM	FOLD Rises 136% in 6 Months: Should You Buy, Sell or Hold the Stock? (Zacks)
06:24AM	Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading (BioPharma Dive)
Jan-15-26 06:19PM	JPM26: Matrix-M Technology is central to Novavaxs strategy (Pharmaceutical Technology)
05:17PM	ALX Oncology Spotlights Evorpacept HER2 Strategy and EGFR ADC ALX2004 Progress at JPM Conference (MarketBeat)
04:20PM	Ocular Launches, And Then Yo-Yoes, On Rumors Sanofi Is Preparing A Bigger Bid (Investor's Business Daily)
02:09PM	State Street's crypto push, FDA delays review of Eli Lilly GLP-1 (Yahoo Finance Video)
10:29AM	Ocular Therapeutix Launches On Rumors Sanofi Is Preparing A Bigger Bid (Investor's Business Daily)
08:53AM	Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week? (Zacks)
08:26AM	FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (Benzinga)
08:12AM	Does Sanofi (SNY) Have a Long Runway for Future Growth? (Insider Monkey)
Jan-14-26 12:18PM	JPM26: Sanofis COAST 1 clinical trials exhibit positive results, with researchers optimistic for COAST 2 results for amlitelimab (Clinical Trials Arena)
Jan-13-26 01:27PM	Thermo Fisher wins contracts as pharma shifts production to US, CEO says (Reuters)
01:02PM	JPM26: Sanofi demonstrates significant strategic progress with several novel drugs (Pharmaceutical Technology)
09:19AM	Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes (Zacks)
Jan-12-26 04:29AM	Sanofi (SNY) Reports Regulatory Win, Barclays Downgrades to 'Equal Weight' with EUR 85 PT (Insider Monkey)
Jan-09-26 07:23AM	J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts (Pharmaceutical Technology)
Jan-07-26 04:18PM	Regeneron Just Moved From Underperform To Buy - Here's Why (Benzinga)
04:05PM	Regeneron Stock Lagged Behind the S&P 500 Last Year. Why This Firm Moved Off the Sidelines. (Barrons.com)
01:01PM	Denali Therapeutics Unveils Portfolio Goals for 2026, Stock Up (Zacks)
Jan-06-26 11:15AM	Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings? (Zacks)
11:12AM	MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine (Zacks)
Jan-05-26 02:38PM	Flu Season's Here-This Dividend-Payer Controls the Shot Market (MarketBeat)
02:29PM	Sanofi and Earendil Labs forge $2.56bn autoimmune deal (Pharmaceutical Technology)
01:45PM	KYMR Skyrockets 82.4% in a Year: More Upside Potential in 2026? (Zacks)
10:26AM	FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children (Zacks)
03:56AM	Novo launches Wegovy pill; Argenx to swap CEOs (BioPharma Dive)
01:40AM	Sanofi Says FDA Agrees to Review Diabetes Drug Age Range (The Wall Street Journal)
Jan-02-26 08:40AM	REGN Soars 41% in Six Months: Is There More Upside Potential in 2026? (Zacks)
Dec-30-25 12:27PM	Jefferies Maintains Buy on Sanofi (SNY) Despite Regulatory Overhang (Insider Monkey)
Dec-29-25 11:59PM	Where is Sanofi (SNY) Headed According to Wall Street? (Insider Monkey)
10:58AM	Sanofi buys hep B vaccine maker for $2.2bn (Pharmaceutical Technology)
05:28AM	Sanofi Agrees to Buy Dynavax for $2.2 Billion After FDA MS Drug Rejection (GuruFocus.com)
03:13AM	Delayed MS Decision and Trial Miss Add to Sanofi's R&D Challenges (Insider Monkey)
Dec-28-25 10:59AM	Sanofi (SNY) to Acquire Dynavax Technologies Corporation (DVAX) (Insider Monkey)
Dec-26-25 03:08AM	Company News for Dec 26, 2025 (Zacks)
Dec-25-25 12:47AM	Asian shares are mixed after US stocks drift to more records (Associated Press Finance)
Dec-24-25 03:55PM	Why Dynavax Stock Soared Today (Motley Fool)
01:24PM	How major US stock indexes fared Wednesday, 12/24/2025 (Associated Press)
01:04PM	Sanofi To Buy Vaccine Maker Dynavax For $2.2 Billion (Investor's Business Daily)
12:08PM	This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. (Barrons.com)
11:55AM	Dynavax Technologies Stock Soars on Buyout Buzz (Schaeffer's Research)
11:24AM	Sanofi to Acquire Dynavax for $2.2 Billion, Expanding Vaccine Portfolio (GuruFocus.com)
11:22AM	FDA Issues CRL to SNY's Regulatory Filing for Multiple Sclerosis Drug (Zacks)
11:07AM	Soft Weekly Jobless Claims Data (Zacks)
10:49AM	Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying (Investopedia)
10:35AM	Xmas Eve Jobless Claims: Still Accommodating (Zacks)
09:59AM	Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise (Zacks)
09:36AM	KB Home downgraded, Costco upgraded: Wall Street's top analyst calls (The Fly)
09:36AM	KB Home downgrade, Costco upgraded: Wall Street's top analyst calls (The Fly)
09:24AM	BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax (Yahoo Finance Video)
07:59AM	This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. (Barrons.com)
07:43AM	Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal (GuruFocus.com)
07:09AM	Nike, UiPath gain in premarket; Intel falls (Investing.com)
06:34AM	Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal (The Wall Street Journal)
04:27AM	Sanofi to Buy Dynavax to Boost Vaccines Business (Bloomberg)
Dec-19-25 05:40PM	Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump (Investor's Business Daily)
04:46PM	Trump reaches deal with 9 drug companies to lower prices (Yahoo Finance Video)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:09PM	More Drugmakers Reach Deals With White House to Lower Prices (The Wall Street Journal)
Dec-18-25 10:51AM	SNY's Rare Disease Drug Efdoralprin Alfa Gets EMA's Orphan Drug Tag (Zacks)
Dec-17-25 05:09PM	Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades (Insider Monkey)
Dec-16-25 01:58PM	Sanofi signs pair of billion-dollar biotech deals to bolster pipeline (Pharmaceutical Technology)
01:01PM	Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals (Pharmaceutical Technology)
10:41AM	SNY Stock Down on Double Trouble With Multiple Sclerosis Drug (Zacks)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNY

Sanofi ADR

Upgrade your FINVIZ experience